Venture Capital News: Breaking Venture Capital News, Comments and Articles. - Page: 4

First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System

WILMINGTON, Del. and MUNICH, May 22, 2013 /PRNewswire/ -- JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic valve disease, announced today its first interim results of the JenaValve EvalUation of Long Term Performance and Safety In PaTients with SEvere AoRtic Stenos...

TheraCoat Has Completed a Capital Raising of $7M led by Pontifax and Chaim Hurvitz's CHealth Fund

TheraCoat Ltd. (TheraCoat), a clinical stage specialty pharmaceutical company focused on innovative drug-delivery solutions for the treatment of intra-cavital diseases, announces today the completion of a successful capital raise of $7M from private investors and venture Funds, both in Israel and abroad. Amongst the investors are Pontifax, and Chaim Hurvit...

Clinical Data on TetraLogic Pharmaceuticals’ Smac Mimetic Birinapant to Be Presented at ASCO

TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced that data from two clinical studies investigating its lead Smac mimetic drug candidate birinapant (formerly TL32711) will be presented at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO) bein...

Sutter Health Gives $150,000 to American Red Cross for Oklahoma Tornado Relief

SACRAMENTO, Calif., May 22, 2013 /PRNewswire/ -- Sutter Health today announced a $150,000 donation to the American Red Cross Capital Region Chapter to support relief efforts following the devastating tornado in Oklahoma this week. "It's almost impossible to comprehend the staggering devastation caused by the massive tornado," said Pat Fry, president and CEO of Sutter Health. "Our hearts are with...

Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer

Dr. Olson’s Extensive Experience in Personalized Medicine Will Support Syros’ Mission to Lead in Gene Control Syros Pharmaceuticals, a newly launched company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases, announced today that Eric R. Olson, Ph.D., has joined the company a

Mayo Clinic Forms Joint Venture with Cancer Genetics

OncoSpire Genomics will seek to discover and commercialize biomarkers for multiple cancer types Mayo Clinic ("Mayo") and Cancer Genetics Inc. (OTCQB: CGIX) today launched OncoSpire Genomics ("OncoSpire"), a joint venture with the singular goal of improving cancer care by discovering and commercializing diagnostic tests that leverage

The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients

WHITE PLAINS, N.Y. , May 22, 2013 /- The Leukemia & Lymphoma Society (LLS) is committing approximately $6 million to Valor Biotherapeutics, LLC, a joint venture between ImmunGene and Caliber, to co-fund the completion of pre-clinical deve...

MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference

HARRISON, N.Y., May 22, 2013 /PRNewswire/ -- MGT Capital Investments, Inc. (NYSE MKT: MGT) announced today that the Company will present at the Second Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in New York City at the Grand Hyatt Hotel.  Robert Ladd, President and Chief Executive Officer, will update investors and answer questions. (Logo: http://photos.prnewswire.co...

Mayo Clinic, Cancer Genetics Form Diagnostics Venture

Allstate Announces Capital Management Plans

NORTHBROOK, Ill., May 22, 2013 /PRNewswire/ -- The Allstate Corporation (NYSE: ALL) today announced a plan to use preferred stock and subordinated debt to refinance a portion of its existing debt. The company expects to retire approximately $3.0 billion of outstanding senior and subordinated bonds by utilizing a combination of preferred stock, debt and cash. "Today's announcement is...

Transwestern's Atlanta Office Raises $17,133 for the Make-A-Wish® Georgia's 9th Annual Walk for Wishes Event

ATLANTA, May 22, 2013 /PRNewswire/ -- Transwestern today announced its Atlanta office raised $17,133 for Make-A-Wish® Georgia, in support of the foundation's 9th annual Walk for Wishes event held on April 20, 2013. These funds will support in excess of two wishes, according to the foundation. Each wish fulfills a critically ill child's dream of being something, meeting someone, traveling some...

Phagenesis Expands Series B Financing to $17 million

Manchester, UK – 22 May 2013 − Phagenesis, the world’s leading company in the treatment of dysphagia, has expanded its Series B financing to $17m. In 2011, Phagenesis announced a €7m Series B financing, led by Inventages Venture Capital. The increased resources will be used to launch the Phagenyx® treatment, which received its CE Mark in 2012, in new territories an...

Chindex International, Inc. to Participate Upcoming Investor Conferences

BETHESDA, Md., May 22, 2013 /PRNewswire/ -- Chindex International, Inc. (NASDAQ: CHDX), an American healthcare company providing healthcare services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced that the Company will participate the upcoming investor conferences: CICC All for Childr...

Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures

CAMBRIDGE, Mass., May 22, 2013 /PRNewswire/ -- Flagship Ventures, a leading venture capital and venture creation firm focused on healthcare and sustainability, today announced the appointment of Stephane Bancel as a Senior Partner. In this role, Mr. Bancel will provide strategic counsel and support to portfolio companies. In addition to working closely with companies in the Flagship portfoli...

Glue Dots International offers video trial service for SD-900 in Europe

Confirm your capital investment. New Berlin, Wisconsin (PRWEB) May 22, 2013 Glue Dots International (GDI), a leading global manufacturer of pressure sensitive adhesive patterns, offers a new free video trial service for the SD-900 adhesive applicator in the European market. The SD-900 is a fully automated, inline adhesive applicator engineered to quickly, cleanly, and easily apply Glue Dots Brand...

Talking Dog Research: MIT Startup GeriJoy and Pace University Collaborate to Determine Clinical Efficacy of Virtual Companions for Senior Care

GeriJoy provides virtual talking dogs as companions for the elderly. Following anecdotal evidence of GeriJoy's senior companionship service improving mental health and even rolling back Alzheimer's, Pace University will begin a research study this summer to determine the clinical efficacy of the GeriJoy Companion system. New York, NY (PRWEB) May 22, 2013 Research shows that loneliness is...

Gulfside Dental Recognizes Mental Health Awareness Month

May is Mental Health Month and Gulfside Dental wants to call attention to strategies and approaches that help all Americans achieve complete wellness which is essential to living a full and productive life. Beaumont, TX (PRWEB) May 22, 2013 May is Mental Health Month and Gulfside Dental wants to call attention to strategies and approaches that help all Americans achieve complete wellness which is...

Prolor Biotech Buyout: Is The Opko Bear Case Now Dead?

By Daniel Lauchheimer:Last month, Opko Health (OPK) bought PROLOR Biotech (PBTH). Shareholders of PBTH will receive just under 1 share of OPK for each share of PBTH. Considering this even trade, current shareholders of PBTH will need to decide if they want to hold onto the OPK shares they receive, or deploy capital somewhere else. In this article I will take a close look at OPK, and try to assess...

SalutarisMD Data for Wet AMD Treatment with Long Term Positive Outcomes Presented at The Royal College of Ophthalmologists Annual Congress

At The Royal College of Ophthalmologists Annual Congress yesterday, results were presented from a cohort study evaluating the use of a minimally invasive retrobulbar episcleral brachytherapy device developed by Salutaris Medical Devices, Ltd. (SalutarisMD®) to treat Wet AMD (Age-related Macular Degeneration), the leading cause of vision loss and blindness...

mumms® Software and Capital Caring Announce Collaborative Agreement

New Orleans, LA, May 22, 2013 --(PR.com)-- mumms® Software, a recognized innovator and developer of hospice and palliative care software, announced a collaborative agreement with Capital Caring, one of the oldest, largest and most experienced hospice and palliative care providers in the United States. A joint announcement was made in New Orleans at the recent Innovation Conference: MUMMS 20...

EnteroMedics to Participate in the Craig-Hallum Annual Institutional Investor Conference

ST. PAUL, MN -- (Marketwired) -- 05/22/13 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company will participate in the Craig-Hallum Annual Institutional Investor Conference in Minneapolis, Minnesota to take place on May 29, 2013. The conferen...

BioSyent Releases First Quarter Results-Sales Increase 70%, Profit Before Tax Up 76%

TORONTO, ONTARIO -- (Marketwired) -- 05/22/13 -- BioSyent Inc. (TSX VENTURE: RX) ("BioSyent") released today a summary of its First Quarter (Q1) 2013 financial results. Total sales for Q1 2013 of $1,541,843, were 70% higher compared to $904,488 in the corresponding prior year period. Net Income Before Tax for the first quarter of 2013 was $481,963, which is 76% higher than $273,184 in the firs...

BC Pet Owners Have a New Weapon Against Dog Breath

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/22/13 -- A brand new, Canadian-made invention is officially in British Columbia now to help improve companion animals' oral hygiene and prevent bad breath. Kane Biotech Inc. (TSX VENTURE: KNE) is pleased to mark the official introduction of its StrixNB pet oral care product to the BC market today at Market Hill Animal Hospital in Vancouver. "Th...

Capital Bank Financial Corp. Announces Hiring of James A. Arndts as BSA Compliance Executive

CORAL GABLES, Fla., May 22, 2013 (GLOBE NEWSWIRE) -- Capital Bank Financial Corp. (Nasdaq:CBF) today announced that James A. Arndts has been appointed BSA Compliance Executive for Capital Bank, N.A. Mr. Arndts experience includes more than 11 years in the design, implementation, monitoring and oversight of BSA/AML compliance programs, most recently as Head, Global Anti-Money Laundering Financial...

Functional Technologies to Apply for Extension of Creditor Protection Period

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/22/13 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") reports that it intends to make court application for an extension of the initial 30 day creditor protection period reported in the Company's news release of April 25, 2013. The Company also reports that Maurice Boucher has resigned from his consulting positions with the...